No. 21-1566
 
Title: Juno Therapeutics, Inc., et al., Petitioners
v.
Kite Pharma, Inc.
Docketed: June 15, 2022
Linked with: 21A461
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2020-1758)
   Decision Date: August 26, 2021
   Rehearing Denied: January 14, 2022
 
Proceedings and Orders
Feb 25 2022 Application (21A461) to extend the time to file a petition for a writ of certiorari from April 14, 2022 to June 13, 2022, submitted to The Chief Justice.
Main Document Lower Court Orders/Opinions Lower Court Orders/Opinions Lower Court Orders/Opinions Proof of Service
Mar 07 2022 Application (21A461) granted by The Chief Justice extending the time to file until June 13, 2022.
Jun 13 2022 Petition for a writ of certiorari filed. (Response due July 15, 2022)
Petition Appendix Appendix Certificate of Word Count Proof of Service
Jun 28 2022 Motion to extend the time to file a response from July 15, 2022 to August 24, 2022, submitted to The Clerk.
Main Document
Jun 29 2022 Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2022.
Jul 15 2022 Brief amicus curiae of City of Hope filed.
Main Document Proof of Service Certificate of Word Count
Jul 15 2022 Brief amici curiae of Mark D. Janis and Timothy R. Holbrook filed.
Main Document Certificate of Word Count Proof of Service
Jul 15 2022 Brief amicus curiae of REGENXBIO Inc. filed.
Main Document Proof of Service Certificate of Word Count
Jul 15 2022 Brief amici curiae of Amgen Inc., et al. filed.
Main Document Proof of Service Certificate of Word Count
Jul 15 2022 Brief amici curiae of St. Jude Children’s Research Hospital, Inc., et al. filed.
Main Document Proof of Service Certificate of Word Count
Aug 24 2022 Brief of respondent Kite Pharma, Inc. in opposition filed.
Main Document Proof of Service Certificate of Word Count
Sep 07 2022 DISTRIBUTED for Conference of 9/28/2022.
Sep 07 2022 Reply of petitioners Juno Therapeutics, Inc., et al. filed. (Distributed)
Main Document Proof of Service Certificate of Word Count
Oct 03 2022 DISTRIBUTED for Conference of 10/7/2022.
Oct 11 2022 DISTRIBUTED for Conference of 10/14/2022.
Oct 24 2022 DISTRIBUTED for Conference of 10/28/2022.
Oct 31 2022 DISTRIBUTED for Conference of 11/4/2022.
Nov 07 2022 Petition DENIED.
Nov 23 2022 Petition for Rehearing filed.
Main Document Certificate of Word Count Proof of Service
Dec 07 2022 DISTRIBUTED for Conference of 1/6/2023.
Jan 09 2023 Rehearing DENIED.
Attorneys
Attorneys for Petitioners
Gregory Andrew Castanias
Counsel of Record
Jones Day
51 Louisiana Ave., NW
Washington, DC 20001

gcastanias@jonesday.com
Ph: (202) 879-3939
Party name: Juno Therapeutics, Inc., et al.


Attorneys for Respondents
E. Joshua Rosenkranz
Counsel of Record
Orrick, Herrington & Sutcliffe LLP
51 West 52nd Street
New York, NY 10019

jrosenkranz@orrick.com
Ph: 212-506-5380
Party name: Kite Pharma, Inc.


Other Attorneys
Matthew James Dowd
Counsel of Record
Dowd Scheffel PLLC
1717 Pennsylvania Avenue, NW
Suite 1025
Washington, DC 20006

mdowd@dowdscheffel.com
Ph: 202-559-9175
Party name: REGENXBIO Inc.


Daralyn Jeannine Durie
Counsel of Record
Durie Tangri LLP
217 Leidesdorff St
San Francisco, CA 94111

ddurie@durietangri.com
Ph: 415-362-6666
Party name: City of Hope


Timothy R. Holbrook
Counsel of Record
Emory University School of Law
1301 Clifton Rd, NE
Atlanta, GA 30322

tholbrook@emory.edu
Ph: 404-712-0353
Party name: Mark D. Janis and Timothy R. Holbrook


Jeffrey Alan Lamken
Counsel of Record
MoloLamken LLP
The Watergate, Suite 500
600 New Hampshire Ave., N.W.
Washington, DC 20037

jlamken@mololamken.com
Ph: 2025562010
Party name: Amgen Inc., Association of University Technology Managers (AUTM), Instil Bio, Inc., Corning Incorporated, Bavarian Nordic A/S, and GlaxoSmithKline plc


Vanessa Y. Yen
Counsel of Record
King & Spalding LLP
1185 Ave. of the Americas, 34th Floor
New York, NY 10036

vyen@kslaw.com
Ph: (212) 556-2100
Party name: St. Jude Children’s Research Hospital, Inc., Albert Einstein College of Medicine, the University of Texas MD Anderson Cancer Center, and Other Academic Research Institutions